Radiological evolution of progestogen-induced meningioma: A monocentric retrospective study.
Fiche publication
Date publication
janvier 2023
Journal
Fundamental & clinical pharmacology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GILLET Pierre, Pr TAILLANDIER Luc, Dr RECH Fabien
Tous les auteurs :
Ahmed-Khalifa T, Gillet R, Blonski M, Rech F, Fresse A, Gillet P, Taillandier L, Petitpain N
Lien Pubmed
Résumé
Cyproterone acetate (CPA) is known to induce meningioma, and recently, nomegestrol acetate (NMA) and chlormadinone acetate (CMA) were also involved. Progestagen-induced meningioma management starts with progestogen discontinuation and is either interventional (surgery and/or radiotherapy) or conservative (clinical and MRI radiological follow-up). We performed a retrospective volumetric radiological outcome study of progestogen-induced meningiomas diagnosed in our hospital.
Référence
Fundam Clin Pharmacol. 2023 01 24;: